Company:  OPGEN INC (OPGN)
Form Type:  S-8
Filing Date:  6/3/2022 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  301-869-9683 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.28  
Change: 
-0.0257 (-8.40%)  
Trade Time: 
Oct 05  
Market Cap: 
$13.53M
Trade OPGN now with

© 2022  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.
Register and access this filing in:     
  FORM S-8
    EXPLANATORY NOTE
    PART I
    PART II
      ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
    ITEM 4. DESCRIPTION OF SECURITIES.
    ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.
      ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
      ITEM 7. EXEMPTIONS FROM REGISTRATION CLAIMED.
      ITEM 8. EXHIBITS.
      ITEM 9. UNDERTAKINGS.
    INDEX TO EXHIBITS TO REGISTRATION STATEMENT ON FORM S-8
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 5.1
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT FILING FEES